Literature DB >> 6741995

Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: data for genetic counselling.

J C Bear, P McManamon, J Morgan, R H Payne, H Lewis, M H Gault, D N Churchill.   

Abstract

Few reports are available on the age-related risk of relatives of affected persons to manifest adult polycystic kidney disease (APKD). For 371 persons in 17 kindreds, at risk for APKD by virtue of having an affected first degree relative, we calculated the estimated probability of clinical diagnosis of APKD to be 0.011 by age 20, 0.041 by age 30, 0.115 by age 40, 0.299 by age 50, and 0.404 by age 60 years (expected = 0.50). Ultrasonographic examination of 172 asymptomatic persons at risk showed definite APKD in 60. The probability of ultrasonographic detection of asymptomatic APKD is estimated as 0.222, 0.657, and 0.855 at age 5, 15, and 25 years, respectively. The probability of having APKD following normal ultrasonogram results (conservatively assuming 90% specificity) is estimated as 0.46, 0.28, and 0.14 for persons at 50% risk in their first, second, or third decade. The marginal benefit of ultrasound as a diagnostic test for APKD for persons in the second or third decade is estimated as 0.37 and 0.41, respectively for a "positive" test and 0.22 and 0.37 for a "negative" test.

Entities:  

Mesh:

Year:  1984        PMID: 6741995     DOI: 10.1002/ajmg.1320180108

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  44 in total

1.  Renal function and healthcare costs in patients with polycystic kidney disease.

Authors:  Krista L Lentine; Huiling Xiao; Gerardo Machnicki; Adrian Gheorghian; Mark A Schnitzler
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

Review 2.  Adult polycystic kidney disease.

Authors:  M L Watson; A M Macnicol; A F Wright
Journal:  BMJ       Date:  1990-01-13

3.  A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2).

Authors:  B Veldhuisen; J J Saris; S de Haij; T Hayashi; D M Reynolds; T Mochizuki; R Elles; R Fossdal; N Bogdanova; M A van Dijk; E Coto; D Ravine; S Nørby; C Verellen-Dumoulin; M H Breuning; S Somlo; D J Peters
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

4.  Genetic and clinical studies in autosomal dominant polycystic kidney disease type 1 (ADPKD1).

Authors:  E Coto; S Aguado; J Alvarez; M J Menéndez Díaz; C López-Larrea
Journal:  J Med Genet       Date:  1992-04       Impact factor: 6.318

Review 5.  Living donor kidney transplantation in patients with hereditary nephropathies.

Authors:  Patrick Niaudet
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

6.  Adult polycystic kidney disease in a kindred of West Indian origin exhibits linkage with the 3'HVR probe on chromosome 16.

Authors:  S Jeffery; A J Wing; M Patton
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

7.  Exclusion of autosomal dominant polycystic kidney disease type II (ADPKD2) from 160 cM of chromosome 1.

Authors:  S Kumar; W J Kimberling; P A Gabow; Y Y Shugart; S Pieke-Dahl
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

8.  Diagnosis of adult polycystic kidney disease by genetic markers and ultrasonographic imaging in a voluntary family register.

Authors:  R G Elles; K A Hodgkinson; N P Mallick; D J O'Donoghue; A P Read; S Rimmer; E A Watters; R Harris
Journal:  J Med Genet       Date:  1994-02       Impact factor: 6.318

9.  Genetic heterogeneity in adult dominant polycystic kidney disease in Cypriot families.

Authors:  C D Constantinou-Deltas; E Papageorgiou; K Boteva; K Christodoulou; M H Breuning; D J Peter; A Pierides
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

10.  A study of genetic linkage heterogeneity in adult polycystic kidney disease.

Authors:  S T Reeders; M H Breuning; M A Ryynanen; A F Wright; K E Davies; A W King; M L Watson; D J Weatherall
Journal:  Hum Genet       Date:  1987-08       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.